A new study reveals that current gabapentinoid use in inflammatory arthritis patients increases fracture risk by 36%. With no ...

Medically reviewed by Lindsay Cook, PharmD Gabapentin is a prescription drug sold under the brand names Neurontin or Gralise ...

The patient's regular noontime dose of gabapentin 300 mg was given, with a 100-mg dose given that evening. In the evening of day 5, the patient's confusion and agitation improved. The next morning ...

Honor has been consistently teasing the arrival of the Honor 300 series of smartphones in China. The lineup is expected to include three models, such as the Honor 300, 300 Pro, and 300 Ultra.

Honor's 300 series is official with the 300, 300 Pro, and 300 Ultra, all with emphasis on the portraits. All three phones feature 50MP main cameras and, more importantly, a 50MP f/2.1 selfie ...

Alongside the standard and Pro models, Honor also unveiled the 300 Ultra smartphone today. As the most expensive model in the series, the 300 Ultra offers a luxurious design, capable cameras, and ...

Honor 300 and Honor 300 Pro are arriving on December 2, the brand revealed on Weibo. Both phones will have MagicOS 9 out of the box, and it seems the Pro will run on Snapdragon 8 Gen 3. The ...

The Sonos Era series is meant to usher in a new generation of speakers for the brand. I’ve tested multiple Sonos speakers and have owned the Era 300 for over a year. Its audio capabilities ...

BAKU, Nov 23 (Reuters) - Countries agreed at the U.N.'s COP29 climate conference to spend $300 billion on annual climate finance. Here are some ways of understanding what that sum is worth: In ...

Komaki has launched the MG PRO Lithium electric scooter series. The scooter is priced at INR 59,999. It offers a range of 150 km on a single charge. The MG PRO has a 2.2 kW and 2.7 kW LiFePO4 battery.

The international-spec MG Cyberster EV comes with a 77 kWh battery pack that has a WLTP-rated range of more than 500 km The Cyberster EV will be the first roadster from MG in India. It will be ...

Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount compared with the original drug. Cheaper competition to off-patent Advair has been ...